rank	phenotype	cui	assoc in neigh	assoc in intom	probability	Benjamini-Hochberg	genes	
95	Hyperammonemia	C0220994	5	39	4.97346754891e-08	3.614916286149163e-05	SLC25A20,CPT2,SLC22A5,CPT1A,SLC25A13
96	Abnormality of nitrogen compound homeostasis	C4025336	6	74	1.17308081693e-07	3.6529680365296805e-05	SLC25A20,APOE,CPT2,SLC22A5,CPT1A,SLC25A13
97	Azotemia	C0242528	6	75	1.288544067e-07	3.691019786910198e-05	SLC25A20,APOE,CPT2,SLC22A5,CPT1A,SLC25A13
106	Myopathy, scapulohumeroperoneal	C0026848	12	450	6.78702068213e-07	4.0334855403348554e-05	SCN5A,SLCO1B1,APOE,OBSL1,CPT2,GFAP,XDH,SLC22A5,ALB,CHKB,LDB3,TRAPPC11
107	Abnormality of metabolism/homeostasis	C4021768	24	1607	7.28239340941e-07	4.071537290715373e-05	SCN5A,SLCO1B1,SLC25A20,NLRC4,KRT9,APOE,CPT2,XDH,GSN,SLC22A5,KRT1,CST3,ALB,CHKB,LDB3,SETX,CAMTA1,SERPING1,GJC2,TRAPPC11,CPT1A,CRB1,SLC25A13,MPO
108	Abnormality of circulating enzyme level	C4023591	8	194	8.28799606278e-07	4.1095890410958905e-05	SCN5A,SLC25A20,CPT2,CHKB,LDB3,SETX,TRAPPC11,CPT1A
109	Elevated serum creatine phosphokinase	C0241005	8	195	8.65066635436e-07	4.147640791476408e-05	SCN5A,SLC25A20,CPT2,CHKB,LDB3,SETX,TRAPPC11,CPT1A
114	Abnormality of circulating protein level	C4023679	9	274	1.77652710254e-06	4.337899543378995e-05	SCN5A,SLC25A20,CPT2,ALB,CHKB,LDB3,SETX,TRAPPC11,CPT1A
120	Alzheimer Disease, Late Onset	C0494463	5	77	3.07412067801e-06	4.5662100456621006e-05	APOE,GFAP,APOC1,TOMM40,CST3
126	Guillain-Barre syndrome, familial	C0018378	4	52	7.49348516427e-06	4.794520547945205e-05	APOE,GFAP,ALB,SERPING1
127	Storage in hepatocytes	C0337174	5	90	7.63949295157e-06	4.832572298325723e-05	APOE,CPT2,SLC22A5,CPT1A,SLC25A13
128	Lipid accumulation in hepatocytes	C1837257	5	90	7.63949295157e-06	4.8706240487062404e-05	APOE,CPT2,SLC22A5,CPT1A,SLC25A13
129	Coma	C0009421	5	93	9.23457836333e-06	4.908675799086758e-05	SLC25A20,CPT2,SLC22A5,CPT1A,SLC25A13
130	Peripheral neuropathy, myopathy, hoarseness, and hearing loss	C0031117	14	756	9.47417308239e-06	4.9467275494672755e-05	NLRC4,APOE,GFAP,GSN,SLC22A5,LDB3,SETX,SERPING1,SACS,GJC2,SPAST,TLN2,CES1,SLC22A8
133	Acute kidney injury	C0022660	8	270	1.23010093152e-05	5.0608828006088275e-05	APOE,CPT2,HP,XDH,CST3,ALB,MPO,SLC22A8
134	Epidermolysis bullosa simplex, Cockayne-Touraine type	C0079298	3	28	1.29349594677e-05	5.098934550989345e-05	KRT9,GFAP,KRT1
135	Hepatic steatosis	C0015695	10	427	1.48991798166e-05	5.1369863013698626e-05	APOE,CPT2,HP,NCOA3,APOC1,SLC22A5,ALB,CPT1A,AHSG,SLC25A13
139	Cognition Disorders	C0009241	4	62	1.78979992549e-05	5.289193302891933e-05	APOE,APOC1,CST3,SPAST
140	Lethargy	C0023380	5	105	1.85301726936e-05	5.3272450532724505e-05	SLC25A20,CPT2,KCNMA1,SLC22A5,CPT1A
144	Cardiac arrest	C0018790	7	223	2.25057193214e-05	5.47945205479452e-05	SCN5A,APOE,SLC22A5,CRAT,SPAST,CPT1A,MPO
145	Hyperlipidemia, combined, 1	C0020473	8	293	2.34762381973e-05	5.5175038051750376e-05	SLCO1B1,APOE,HP,APOC1,ALB,CDCP1,CPT1A,SLC25A13
146	Plaque, Atherosclerotic	C0011389	7	226	2.47641804596e-05	5.555555555555555e-05	APOE,GFAP,GSN,CST3,ALB,SERPING1,CRAT
147	Cardiomyopathy, Dilated	C0007193	10	454	2.61874309037e-05	5.593607305936073e-05	SCN5A,KRT9,APOE,CPT2,GFAP,SLC22A5,CHKB,LDB3,CPT1A,CTSL
197	Shock, Septic	C0036974	4	69	3.01936605231e-05	7.496194824961948e-05	SCN5A,APOE,HP,MPO
198	Impaired vibratory sensation	C1295585	3	35	3.2159254534e-05	7.534246575342465e-05	SETX,SACS,SPAST
199	Abnormality of lipid metabolism	C4025650	6	172	3.34007327022e-05	7.572298325722983e-05	APOE,CPT2,SLC22A5,ALB,CPT1A,SLC25A13
200	Bulbous nose	C0240543	4	72	3.71247724607e-05	7.6103500761035e-05	OBSL1,CPT2,CAMTA1,AP4E1
205	Spastic	C0443306	3	37	4.02395301844e-05	7.800608828006089e-05	APOE,GJC2,SPAST
206	Corneal Diseases	C0010034	3	37	4.02395301844e-05	7.838660578386605e-05	APOE,GFAP,GSN
207	Complications of Diabetes Mellitus	C0342257	4	75	4.52290192526e-05	7.876712328767124e-05	APOE,HP,ALB,MPO
210	Dysmetria	C0234162	4	78	5.4638231758e-05	7.990867579908676e-05	SETX,CAMTA1,SACS,GJC2
211	Chronic Kidney Insufficiency	C0403447	6	186	5.49124536313e-05	8.028919330289193e-05	APOE,HP,XDH,CST3,ALB,AHSG
212	Alcoholic Steatohepatitis	C2718067	3	40	5.50139696556e-05	8.066971080669711e-05	NLRC4,APOE,BBC3
213	Influenza	C0021400	10	497	5.93260568934e-05	8.105022831050228e-05	NLRC4,CPT2,HP,ALB,SETX,SERPING1,SLA2,CRAT,MPO,SLC22A8
217	Confusion	C0009676	3	41	6.07169503577e-05	8.257229832572298e-05	APOE,SLC22A5,SLC25A13
218	Azorean disease	C0024408	4	80	6.17046295078e-05	8.295281582952816e-05	APOE,GFAP,BBC3,CST3
219	Cerebral edema	C0006114	4	80	6.17046295078e-05	8.333333333333333e-05	APOE,CPT2,GFAP,SLC25A13
220	Elevated hepatic transaminases	C1848701	5	130	6.17676369015e-05	8.37138508371385e-05	SLC25A20,CPT2,SLC22A5,CPT1A,SLC25A13
221	Erythroblastosis	C0272138	3	42	6.68390598272e-05	8.409436834094368e-05	GSN,PLAG1,KLK3
222	Mental deterioration	C0234985	6	192	6.70795745913e-05	8.447488584474885e-05	APOE,APOC1,TOMM40,CST3,SPAST,MPO
226	Diabetes mellitus type 2	C0011860	23	1972	7.46805363311e-05	8.599695585996955e-05	SCN5A,SLCO1B1,HPX,PEG3,APOE,HP,APOC1,THRAP3,GSN,TOMM40,CST3,ALB,TSC22D1,CAMTA1,DCD,DGKG,CRAT,CPT1A,AHSG,CTSL,CES1,CRB1,MPO
227	Neuropathy ataxia retinitis pigmentosa syndrome	C0442874	7	265	7.61661361184e-05	8.637747336377474e-05	APOE,GSN,ALB,LDB3,SETX,SERPING1,SACS
228	Motor Neuron Disease	C0085084	5	136	7.93573671775e-05	8.67579908675799e-05	APOE,HP,GFAP,SETX,SPAST
292	Nephrotic Syndrome, Minimal Change	C1704321	3	44	8.04149853322e-05	0.0001111111111111111	HPX,APOE,ALB
293	Pointed chin	C1844505	3	45	8.79065382134e-05	0.00011149162861491629	OBSL1,CAMTA1,AP4E1
298	Diabetic Nephropathies	C0011881	11	616	9.20617750899e-05	0.00011339421613394216	APOE,HP,XDH,APOC1,CST3,ALB,TSC22D1,CRAT,AHSG,MPO,SLC22A8
299	Abnormality of the myocardium	C4025758	8	351	9.4622634834e-05	0.00011377473363774734	SCN5A,SLC25A20,CPT2,GSN,SLC22A5,CHKB,LDB3,CPT1A
300	Autosomal dominant non-syndromic sensorineural deafness type DFNA	C0443147	17	1262	9.57850301387e-05	0.00011415525114155251	SCN5A,NLRC4,KRT9,APOE,KCNMA1,GFAP,GSN,KRT1,CST3,LDB3,PLAG1,SETX,CAMTA1,SERPING1,GJC2,SPAST,AP4E1
301	cardiac event	C0741923	3	46	9.58926723932e-05	0.00011453576864535768	SCN5A,HP,SLC22A5
302	Left ventricular hypertrophy	C0149721	7	274	9.6038458115e-05	0.00011491628614916286	SCN5A,APOE,CPT2,SLC22A5,CST3,CPT1A,CROT
303	Diabetic Angiopathies	C0011875	4	88	9.72738879571e-05	0.00011529680365296803	APOE,HP,ALB,MPO
304	Pancreatitis	C0030305	7	277	0.000103547450809	0.00011567732115677321	APOE,NCOA3,XDH,ALB,CTSL,SLC25A13,MPO
305	Sickle Cell Trait	C0037054	3	47	0.00010439287643	0.00011605783866057838	APOE,HP,SLC22A5
309	Polyneuropathy, hearing loss, ataxia, retinitis pigmentosa, and cataract	C0152025	4	90	0.000108225887261	0.00011757990867579908	GSN,ALB,LDB3,SETX
310	Increased antibody level in blood	C0151669	3	48	0.000113426751192	0.00011796042617960426	KRT9,KRT1,SETX
311	Pelvic inflammatory disease	C0242172	3	48	0.000113426751192	0.00011834094368340943	CST3,SERPING1,MPO
